{"schema_version":"1","generated_at":"2026-11-04T14:21:39.403Z","data_as_of":null,"url":"https://www.findmykol.com/kol/saurabh-zanwar","json_url":"https://www.findmykol.com/kol/saurabh-zanwar/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"saurabh-zanwar","name":"Saurabh Zanwar","credential":"MBBS","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"Mayo Clinic","institution_url":"https://www.findmykol.com/institution/mayo-clinic","city":"Rochester","state":"MN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1245890003","orcid":"0000-0001-5074-8453","openalex":"A5076071872"},"summary":"Saurabh Zanwar is a Hematology physician affiliated with Mayo Clinic. OpenAlex indexes 242 publications with 1,780 citations (h-index 24).","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":242,"cited_by_count":1780,"h_index":24,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Legend Biotech USA Inc.","program_year":2025,"amount_usd":18.26,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1245890003"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1245890003","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":53.8,"classes_total":2,"classes":[{"class":"Thalidomide Analog","setting":"prescribed","share_pct":32.7,"drugs":[{"name":"Lenalidomide","share_pct":100}],"max_beneficiaries":null},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":21.2,"drugs":[{"name":"Tagrisso","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":23.1,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":23.1,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":23.1,"classes_total":1,"classes":[{"class":"Calcium channel blocker","setting":"prescribed","share_pct":23.1,"drugs":[{"name":"Amlodipine Besylate","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Extramedullary Multiple Myeloma: Challenges and Opportunities","year":2025,"journal":"Current Oncology","source_url":"https://doi.org/10.3390/curroncol32030182","status":"verified"},{"title":"Current risk stratification and staging of multiple myeloma and related clonal plasma cell disorders","year":2025,"journal":"Leukemia","source_url":"https://doi.org/10.1038/s41375-025-02654-y","status":"verified"},{"title":"Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025016619","status":"verified"},{"title":"Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants","year":2025,"journal":"Leukemia","source_url":"https://doi.org/10.1038/s41375-025-02526-5","status":"verified"},{"title":"Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma","year":2025,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-025-01232-w","status":"verified"}],"source":"works"},"contact":{"address_1":"200 1ST ST SW","city":"Rochester","state":"MN","zip":"559050002","phone":"507-284-2511","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1245890003","source":"identity"},"similar":[{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"S Rajkumar","slug":"s-rajkumar","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/s-rajkumar","json_url":"https://www.findmykol.com/kol/s-rajkumar/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Ayalew Tefferi","slug":"ayalew-tefferi","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/ayalew-tefferi","json_url":"https://www.findmykol.com/kol/ayalew-tefferi/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"},{"name":"Jaroslaw Maciejewski","slug":"jaroslaw-maciejewski","institution":"Cleveland Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/jaroslaw-maciejewski","json_url":"https://www.findmykol.com/kol/jaroslaw-maciejewski/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-07-01","provider_certified":"2025-07-01","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}